Progress in prostate cancer chemoprevention: modulators of promotion and progression.
Lieberman
R
R
Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland, USA
Bermejo
C
C
Akaza
H
H
Greenwald
P
P
Fair
W
W
Thompson
I
I
D019883:Alkyl and Aryl Transferases / Q000037:antagonists & inhibitors; D000726:Androgen Antagonists / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D016588:Anticarcinogenic Agents / Q000627:therapeutic use*; D000975:Antioxidants / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000097:blood; D004359:Drug Therapy, Combination; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D004965:Estrogen Antagonists / Q000627:therapeutic use; D006801:Humans; D008297:Male; D018977:Micronutrients / Q000627:therapeutic use; D008875:Middle Aged; D011230:Precancerous Conditions / Q000097:blood / Q000188:drug therapy / Q000517:prevention & control*; D019048:Prostatic Intraepithelial Neoplasia / Q000097:blood / Q000188:drug therapy / Q000517:prevention & control*; D011471:Prostatic Neoplasms / Q000097:blood / Q000188:drug therapy / Q000517:prevention & control*; D030262:Soybean Proteins / Q000627:therapeutic use; D013256:Steroids; D014807:Vitamin D / Q000031:analogs & derivatives / Q000627:therapeutic use
D000726:Androgen Antagonists; D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D016588:Anticarcinogenic Agents; D000975:Antioxidants; D014408:Biomarkers, Tumor; D004791:Enzyme Inhibitors; D004965:Estrogen Antagonists; D018977:Micronutrients; D030262:Soybean Proteins; D013256:Steroids; D014807:Vitamin D; D019883:Alkyl and Aryl Transferases; C064911:p21(ras) farnesyl-protein transferase